Memo Therapeutics increases Series C financing to CHF 45 million PRESS RELEASE Memo Therapeutics increases Series C financing to CHF 45 million Additional CHF 20 million raised from new investors Ysios Capital and Kurma Partners as well as from existing...

Memo Therapeutics AG Strengthens Management Team PRESS RELEASE Memo Therapeutics AG Strengthens Management Team Appoints Kristie B. Clemmer as VP Clinical Operations and Dr. Maartje Verschuur as VP CMC and Supply Chain Management                 ...